FDA Inspection 1195740 — Endo USA, Inc.

Endo USA, Inc. — FEI 3006537159

The FDA completed an inspection of Endo USA, Inc. on Dec 22, 2022 in Horsham, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Dec 22, 2022
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Horsham, PA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.